Mark W. True
Impact in
-
- Diabetes Management and Research
- Diabetes Management and Education
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
-
- Parathyroid Disorders and Treatments
Papers in
-
- Diabetes Management and Research 6
- Diabetes Management and Education 6
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Co-authors
- Jana Wardian (15 shared papers)Joshua D. Hartzell (1 shared paper)Roger Shih (1 shared paper)Joseph Brennan (1 shared paper)Stephen Maturo (1 shared paper)Brian M. Faux (3 shared papers)David Bell (2 shared papers)Michael J. Morris (3 shared papers)
- Journals
- Endocrine Practice (4 papers)Journal of Evaluation in Clinical Practice (2 papers)Military Medicine (12 papers)Quality Management in Health Care (1 paper)Diabetes Technology & Therapeutics (1 paper)
- Partner nations
- United StatesIndiaNorway
In The Last Decade
Mark W. True
28 papers receiving 238 citations
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 115
- Nephrology 21
- Family Practice 6
- Research and Theory 2
- Public Health, Environmental and Occupational Health 59
Countries citing papers authored by Mark W. True
This map shows the geographic impact of Mark W. True's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. True with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. True more than expected).
Fields of papers citing papers by Mark W. True
This network shows the impact of papers produced by Mark W. True. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. True. The network helps show where Mark W. True may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark W. True, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 30 | |
| 2 | 2009 | 27 | |
| 3 | 2009 | 25 | |
| 4 | 2018 | 20 | |
| 5 | 2017 | 17 | |
| 6 | 2021 | 14 | |
| 7 | 2016 | 11 | |
| 8 | 2019 | 10 | |
| 9 | 2020 | 10 | |
| 10 | 2018 | 9 | |
| 11 | 2022 | 8 | |
| 12 | 2018 | 7 | |
| 13 | 2017 | 7 | |
| 14 | 2014 | 7 | |
| 15 | 2017 | 7 | |
| 16 | 2019 | 7 | |
| 17 | 2016 | 6 | |
| 18 | 2016 | 6 | |
| 19 | 2018 | 5 | |
| 20 | 2018 | 4 |
About Mark W. True
Mark W. True is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health, General Health Professions, Molecular Biology and Pharmacology, having authored 32 papers that have together received 252 indexed citations. Recurring topics across this work include Diabetes Management and Research (6 papers), Diabetes Management and Education (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Pharmacology and Obesity Treatment (4 papers), Primary Care and Health Outcomes (4 papers), Occupational Health and Performance (3 papers) and Diversity and Career in Medicine (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (115 citations), Nephrology (21 citations), Family Practice (6 citations), Research and Theory (2 citations) and Public Health, Environmental and Occupational Health (59 citations). Mark W. True has collaborated with scholars based in United States, India and Norway. Frequent co-authors include Jana Wardian, Joshua D. Hartzell, Roger Shih, Joseph Brennan, Stephen Maturo, Brian M. Faux, David Bell, Michael J. Morris, Renee Matos and Heather C. Yun. Their work appears in journals such as Endocrine Practice, Journal of Evaluation in Clinical Practice, Military Medicine, Quality Management in Health Care and Diabetes Technology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.